Smith Group Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$7K Hold
120
﹤0.01% 270
2021
Q4
$9K Buy
+120
New +$8.27K ﹤0.01% 315
2020
Q1
Sell
-78,710
Closed -$5.12M 368
2019
Q4
$5.12M Sell
78,710
-33,400
-30% -$2.18M 0.21% 86
2019
Q3
$7.11M Sell
112,110
-760
-0.7% -$49.7K 0.25% 89
2019
Q2
$7.63M Sell
112,870
-1,540
-1% -$101K 0.26% 91
2019
Q1
$7.44M Buy
+114,410
New +$7.6M 0.24% 89
2017
Q4
Sell
-110,620
Closed -$8.96M 451
2017
Q3
$8.96M Buy
+110,620
New +$8.46M 0.3% 80
2016
Q3
Sell
-380,043
Closed -$31.7M 470
2016
Q2
$31.7M Sell
380,043
-605,688
-61% -$53.8M 0.95% 39
2016
Q1
$90.7M Buy
985,731
+13,354
+1% +$1.2M 2.71% 3
2015
Q4
$98.4M Buy
972,377
+200,522
+26% +$20.9M 2.91% 4
2015
Q3
$75.8M Sell
771,855
-46,129
-6% -$5.12M 2.88% 3
2015
Q2
$95.7M Buy
817,984
+175,840
+27% +$19.2M 3.23% 2
2015
Q1
$63M Sell
642,144
-158,732
-20% -$16.1M 2.11% 5
2014
Q4
$75.6M Sell
800,876
-2,027
-0.3% -$210K 2.65% 4
2014
Q3
$85.5M Sell
802,903
-51,455
-6% -$5.04M 3.17% 2
2014
Q2
$70.9M Buy
854,358
+583,550
+215% +$45.4M 2.62% 2
2014
Q1
$19.2M Buy
+270,808
New +$21.2M 0.73% 66

Other funds holding GILD

Smith Group Asset Management's GILD Position: Q1 2022 in Review

Smith Group Asset Management held its Gilead Sciences (GILD) position steady in Q1 2022 at 120 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

Smith Group Asset Management first reported a position in GILD in Q1 2014 and has held it in 17 quarters since. The position peaked at $98.4M in Q4 2015. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Smith Group Asset Management held 120 shares of Gilead Sciences worth $7K as of Q1 2022.
  • Smith Group Asset Management left its Gilead Sciences share count unchanged in Q1 2022.
  • Gilead Sciences made up ﹤0.01% of Smith Group Asset Management's portfolio in Q1 2022, its #270 holding.
  • Smith Group Asset Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 17 quarters since.
  • Smith Group Asset Management's Gilead Sciences position peaked at $98.4M in Q4 2015.
  • 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.